Drug Shortage Report for MYLAN-PANTOPRAZOLE

Last updated on 2018-07-05 History
Report ID 200
Drug Identification Number 02299585
Brand name MYLAN-PANTOPRAZOLE
Common or Proper name PANTOPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 500BT, 100BT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-07-03
Estimated end date Unknown
Actual end date 2018-07-03
Shortage status Resolved
Updated date 2018-07-05
Company comments Discontinued in ID 51513
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v72 2018-07-05 French Compare
v71 2018-07-05 English Compare
v70 2018-07-04 English Compare
v69 2018-07-03 French Compare
v68 2018-07-03 English Compare
v67 2018-06-05 French Compare
v66 2018-06-05 English Compare
v65 2018-03-26 French Compare
v64 2018-03-26 English Compare
v63 2018-03-07 French Compare
v62 2018-03-07 English Compare
v61 2018-03-05 French Compare
v60 2018-03-05 English Compare
v59 2018-02-27 French Compare
v58 2018-02-27 English Compare
v57 2018-02-23 French Compare
v56 2018-02-23 English Compare
v55 2018-02-16 French Compare
v54 2018-02-16 English Compare
v53 2018-02-02 French Compare

Showing 1 to 20 of 72